[HTML][HTML] Emerging role of the spleen in the pharmacokinetics of monoclonal antibodies, nanoparticles and exosomes
M Cataldi, C Vigliotti, T Mosca, MR Cammarota… - International journal of …, 2017 - mdpi.com
After being absorbed, drugs distribute in the body in part to reach target tissues, in part to be
disposed in tissues where they do not exert clinically-relevant effects. Therapeutically …
disposed in tissues where they do not exert clinically-relevant effects. Therapeutically …
[HTML][HTML] NF-kB's contribution to B cell fate decisions
C Guldenpfennig, E Teixeiro, M Daniels - Frontiers in immunology, 2023 - frontiersin.org
NF-κB signaling is essential to an effective innate and adaptive immune response. Many
immune-specific functional and developmental outcomes depend in large on NF-κB. The …
immune-specific functional and developmental outcomes depend in large on NF-κB. The …
Lymphoma development in patients with autoimmune and inflammatory disorders–what are the driving forces?
E Baecklund, KE Smedby, LA Sutton, J Askling… - Seminars in cancer …, 2014 - Elsevier
For decades, it has been known that patients with certain autoimmune and inflammatory
disorders, such as rheumatoid arthritis (RA) and primary Sjögren's syndrome (pSS), have an …
disorders, such as rheumatoid arthritis (RA) and primary Sjögren's syndrome (pSS), have an …
[HTML][HTML] Epstein-Barr virus in systemic lupus erythematosus, rheumatoid arthritis and multiple sclerosis—association and causation
A Lossius, JN Johansen, Ø Torkildsen, F Vartdal… - Viruses, 2012 - mdpi.com
Epidemiological data suggest that the Epstein-Barr virus (EBV) is associated with several
autoimmune diseases, such as systemic lupus erythematosus, rheumatoid arthritis and …
autoimmune diseases, such as systemic lupus erythematosus, rheumatoid arthritis and …
[HTML][HTML] B cell-activating factor (BAFF) from dendritic cells, monocytes and neutrophils is required for B cell maturation and autoantibody production in SLE-like …
D Giordano, R Kuley, KE Draves, KB Elkon… - Frontiers in …, 2023 - frontiersin.org
Purpose and methods B cell-activating factor (BAFF) contributes to the pathogenesis of
autoimmune diseases including systemic lupus erythematosus (SLE). Although several anti …
autoimmune diseases including systemic lupus erythematosus (SLE). Although several anti …
Overexpression of TLR7 promotes cell-intrinsic expansion and autoantibody production by transitional T1 B cells
NV Giltiay, CP Chappell, X Sun, N Kolhatkar… - Journal of Experimental …, 2013 - rupress.org
Toll-like receptor (TLR), a ligand for single-stranded RNA, has been implicated in the
development of pathogenic anti-RNA autoantibodies both in systemic lupus erythematous …
development of pathogenic anti-RNA autoantibodies both in systemic lupus erythematous …
[HTML][HTML] Sjögren's syndrome: still not fully understood disease
M Maślińska, M Przygodzka, B Kwiatkowska… - Rheumatology …, 2015 - Springer
Primary Sjögren's syndrome is an autoimmune disorder with external exocrine glands
dysfunction and multiorgan involvement. The pathogenesis of primary Sjogren's syndrome is …
dysfunction and multiorgan involvement. The pathogenesis of primary Sjogren's syndrome is …
Ectopic germinal centers, BAFF and anti-B-cell therapy in myasthenia gravis
S Berrih-Aknin, S Ragheb, R Le Panse, RP Lisak - Autoimmunity reviews, 2013 - Elsevier
Myasthenia gravis (MG) is an autoimmune disease mediated by antibodies directed to
molecules of the endplate of the neuromuscular junction. B cells play a major role in MG …
molecules of the endplate of the neuromuscular junction. B cells play a major role in MG …
[HTML][HTML] B-cell selection and the development of autoantibodies
NV Giltiay, CP Chappell, EA Clark - Arthritis research & therapy, 2012 - Springer
The clearest evidence that B cells play an important role in human autoimmunity is that
immunotherapies that deplete B cells are very effective treatments for many autoimmune …
immunotherapies that deplete B cells are very effective treatments for many autoimmune …
Targeting primary Sjögren's syndrome
T Odani, JA Chiorini - Modern rheumatology, 2019 - academic.oup.com
Primary Sjögren's syndrome (pSS) is a chronic autoimmune disease that is estimated to
affect 35 million people worldwide. Hallmarks of the disease are a loss of salivary and …
affect 35 million people worldwide. Hallmarks of the disease are a loss of salivary and …